Patients are telling C3 that they are being turned away from scheduled cancer treatment because of a new shortage of leucovorin, a drug that is commonly used in colon and rectal cancer treatment. However, good news is on the way.
TEVA Pharmaceuticals has told the Food and Drug Administration that they are shipping back orders of leucovorin now and that the drug should be in oncology clinics and doctor’s offices next week.
The FDA has put leucovorin on its drugs shortages list, citing manufacturing delays as the reason. The American Society of Health-System Pharmacists (AHSP) has additional details on the shortage. Read the rest of this entry »